Leading drug maker Moderna started to experiment adding booster shots to its mRNa- technology to detect the impact of the booster shots on the Omicron.
The test aimed to check the impact of the booster vaccine doses on neutralise the new strain that carried 32 mutations in its protein spike.
It began by testing three different kinds of COVID-19 vaccines, and the higher boosters gave more protection from entering hospital. In addition, the company is working on developing two of its belongings especially the bags.
Stéphane Bancel, Chief Executive Officer of Moderna, in an official statement: “From the beginning, we have said that as we seek to defeat the pandemic; it is imperative that we are proactive as the virus evolves. The mutations in the Omicron variant are concerning and for several days, we have been moving as fast as possible to execute our strategy to address this variant.”
Therefore, the World Health Organization (WHO) will hold a special and urgent meeting on Friday to discuss the new variant.
South African scientists detected at least 30 mutations in the spike protein of the virus, according to scientist Tulio de Oliveira.
WHO official Dr. Maria Van Kerkhove said: “We don’t know very much about this yet. What we do know is that this variant has a large number of mutations. And the concern is that when you have so many mutations, it can have an impact on how the virus behaves.”
Until now, a few cases of the new strain were reported in Botswana, Hong Kong, and Israel.